W. L. Gore & Associates, Inc. Release: Rush University Medical Center First to Enroll Patient in the Gore REDUCE Clinical Study for the Indication of Patent Foramen Ovale (PFO) Closure

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that Rush University Medical Center (Chicago, Illinois) is the first medical center to enroll a patient in the Gore REDUCE Clinical Study*. This milestone was achieved by the site’s study co-investigators, Ziyad Hijazi, MD, Director of the Rush Center for Congenital and Structural Heart Disease and Professor of Pedatrics and Internal Medicine, and Vivien Lee, MD, Stroke Neurologist.

MORE ON THIS TOPIC